Home › Billing code Q5126
Q5126
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Medicaid paid $418K on code Q5126 from 2018 through 2024, to 5 providers — the #4,757 code in the file by dollars. 69% of it was billed in California.
28Total paid$418K
24GClaims627
Paid per claim line$666.58
33Providers billing it5
Box 32 · Location
Where Q5126 is billed
The largest of 4 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.
Ranked
Top providers billing Q5126
| # | Provider | Location | Claims | Paid on Q5126 |
|---|---|---|---|---|
| 1 | Blood and Cancer Therapeutics a Medical Corporation | Bakersfield, CA | 134 | $203K |
| 2 | County of Santa Clara | San Jose, CA | 327 | $85K |
| 3 | American Oncology Partners PA | Columbus, OH | 47 | $70K |
| 4 | Henry Ford Health ST. John Hospital | Chicago, IL | 27 | $42K |
| 5 | Boston Medical Center Corporation | Boston, MA | 92 | $18K |